Real-time enrollment status for this bipolar disorder clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 4:26 PM UTC
| NCT Number | NCT06951711 |
| Recruiting Status | Recruiting |
| Condition | Bipolar Disorder |
| Phase | PHASE3 |
| Target Enrollment | 274 participants |
| Active Locations | 28 sites in the US |
| Sponsor | Bristol-Myers Squibb |
| Last Updated on CT.gov | June 4, 2026 (Jun 4, 2026) |
As of July 17, 2026: Clinical trial NCT06951711 is currently recruiting participants. This phase3 study for bipolar disorder is actively seeking new participants at 28 locations across the United States. The study is sponsored by Bristol-Myers Squibb. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06951711 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 28 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06951711 was last updated Jun 4, 2026 (June 4, 2026). HelloStudys verifies this status automatically.